<SEC-DOCUMENT>0001209191-23-008564-index.html : 20230210
<SEC-HEADER>0001209191-23-008564.hdr.sgml : 20230210
<ACCEPTANCE-DATETIME>20230210195759
ACCESSION NUMBER:		0001209191-23-008564
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230208
FILED AS OF DATE:		20230210
DATE AS OF CHANGE:		20230210

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Patterson Joshua F.
		CENTRAL INDEX KEY:			0001805702

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38716
		FILM NUMBER:		23614199

	MAIL ADDRESS:	
		STREET 1:		C/O AKCEA THERAPEUTICS, INC.
		STREET 2:		22 BOSTON WHARF ROAD, 9TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gamida Cell Ltd.
		CENTRAL INDEX KEY:			0001600847
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		5 NAHUM HAFZADI STREET
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			95484
		BUSINESS PHONE:		97226595666

	MAIL ADDRESS:	
		STREET 1:		5 NAHUM HAFZADI STREET
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			95484
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
Document 1 - file: doc4.html

Document 1 - RAW XML: doc4.xml

</DOCUMENT>
</SEC-DOCUMENT>